Clinical trials
Immunity clinical trials
Below are recruiting immunity clinical trials, each written for real people, not researchers. We’re tracking 973 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07338786Enrolling by invitationPhase 1
Rabies vaccine safety trial for ages 10 to 60
This trial tests a freeze-dried rabies vaccine to see how safe it is when given on different schedules. It may be an option for people who need protection from rabies.
Xuzhou, JiangsuAges 10–60 - NCT05328856Recruiting
Vital shower study to improve well-being and body regulation
This trial studies whether a special “vital shower” can improve quality of life, immune-related measures, heart/blood-pressure regulation, and overall well-being. You may be a fit if you’re generally healthy enough and can safely use the shower setup during the study.
Berlin, State of BerlinAges 18–70 - NCT07339488RecruitingPhase 2
Low-dose radiation and immunotherapy to shrink hard-to-remove esophageal cancer
This trial tests a treatment approach that combines low-dose radiation with immunotherapy and chemotherapy for people with esophageal cancer that is hard to remove with surgery. The goal is to shrink the tumor enough to make surgery possible, which could improve outcomes.
Shantou, GuangdongAges 18–75 - NCT07339189Recruiting
AI Suicide Prevention for Older Adults With HIV
This trial tests a smartphone-based AI program designed to help people with HIV who have had suicidal thoughts. It aims to reduce suicide risk by teaching coping skills through text-based conversations.
Newark, New JerseyAges 50 years+ - NCT07339254Recruiting
Survey about immunotherapy for lung cancer patients
This study is a survey to learn about the experiences and feelings of people with non-small cell lung cancer who are taking immunotherapy drugs. The goal is to understand how you're doing on treatment, which can help improve care for others.
Los Angeles, CaliforniaAges 18 years+ - NCT07341321Recruiting
Covid-19 vaccine in liver cancer patients on immunotherapy
This study looks at how the COVID-19 mRNA vaccine works in people with liver cancer who are being treated with immunotherapy. It may help show if the vaccine is safe and effective for this group of patients.
GrazAges Any age - NCT06862843Recruiting
Family eating habits and chronic inflammation study
This study looks at how eating habits and family health history relate to chronic inflammatory conditions like Crohn's disease, ulcerative colitis, and juvenile idiopathic arthritis. It aims to understand these links by studying families with a child or adult affected by these conditions, as well as healthy families.
Florence, ItalyAges Any age - NCT06864975RecruitingPhase 4
Different doses of ADVATE for immune tolerance in boys with hemophilia A and inhibitors
This trial tests how different doses and schedules of the factor VIII medicine ADVATE can train the immune system to accept factor VIII again in boys with hemophilia A who have developed inhibitors. The goal is to find a better way to help their bodies stop blocking the treatment.
Beijing, Beijing MunicipalityAges birth–18 years - NCT07330596RecruitingPhase 2
Study of QL1706 plus chemo for lung cancer that got worse after immunotherapy
This trial tests a new drug called QL1706 combined with chemotherapy for people with non-small cell lung cancer that has spread or come back after previous treatment with an immunotherapy drug (PD-1/PD-L1 inhibitor) plus chemotherapy. The goal is to see if this combination can help shrink or control the cancer.
HefeiAges 18–75 - NCT07325565Recruiting
Emotional health and immunotherapy for liver cancer
This trial studies how emotional well-being affects how well immunotherapy works for liver cancer. It is for people newly diagnosed with liver cancer who have not yet been treated.
Wuhan, HubeiAges 18–75 - NCT07316465Recruiting
Tracking immune markers in newborns at risk for eczema
This study follows newborns for two years to see how their immune system develops, especially if they have a family history of eczema, asthma, or hay fever. Researchers want to learn if certain immune markers appear early in babies who later develop eczema.
Jette, Brussels CapitalAges 1 hour–2 years - NCT07308886RecruitingPhase 2
CYT107 for Kaposi sarcoma in HIV patients with low CD4
This trial tests an experimental drug (CYT107) that boosts the immune system to help fight Kaposi sarcoma in people with HIV who have a low CD4 count despite good HIV treatment. It aims to see if the drug can improve KS tumors and quality of life.
Bethesda, MarylandAges 18–120 - NCT07314359Recruiting
Study of a biofield patch on antioxidants and energy
This study tests a special patch (called a biofield patch) to see if it can improve your body's antioxidant levels and energy. It involves several clinic visits with blood draws over a short time period.
Klamath Falls, OregonAges 18–75 - NCT05846620Recruiting
Study of lung immune cells and the gut microbiome
This study looks at how immune cells in the lungs relate to the microbiome (the helpful microbes in the gut) in healthy adults. It may help scientists understand what affects lung health and immune balance.
HvidovreAges 40–75 - NCT06635954Recruiting
Blood test to predict response to immunotherapy
This study is testing a blood test (Episwitch CiRT®) that looks at your DNA to see if it can predict whether you will respond to a type of immunotherapy called PD-(L)-1 checkpoint inhibitors. The goal is to see if this test is accurate across many different types of cancer.
Norwich, ConnecticutAges 18 years+ - NCT05795257Recruiting
Studying lung immune cells and gut microbes in ARDS
This trial studies how immune cells in the lungs and gut microbes (your microbiome) change during ARDS and how these changes relate to your outcomes. It may help researchers better predict and treat ARDS by learning what’s going on in the lungs and body systems.
HvidovreAges 18 years+ - NCT07292493Enrolling by invitation
Immune system study for diabetic kidney disease
This study looks at how the immune system works in people with diabetic kidney disease. It tests whether certain blood pressure medicines can help protect the kidneys.
LjubljanaAges 40–65 - NCT07295535Recruiting
Nasal immune responses to respiratory viruses in healthy and immunocompromised people
This study looks at how the nose's immune system responds to common respiratory viruses in both healthy people and those with weakened immune systems. It aims to understand how long these responses last.
Pavia, PaviaAges 18–90 - NCT07293754RecruitingPhase 1/Phase 2
Study of RPTR-1-201 for advanced solid tumors
This trial tests a new drug called RPTR-1-201 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective.
Grand Rapids, MichiganAges 18 years+ - NCT07286370RecruitingPhase 2
Vaccine study for typhoid and salmonella in infants
This study tests a new vaccine that could protect infants against typhoid fever and a serious type of salmonella. If your baby is healthy and within the age range, they may be eligible to participate.
BanjulAges 1 month–6 months - NCT07279077RecruitingPhase 2
Low-dose radiation with chemo and immunotherapy for high-risk colon cancer
This trial tests a combination of low-dose radiation, chemotherapy, and an immunotherapy drug (PD-1 inhibitor) for people with a specific type of high-risk colon cancer that has not spread. The goal is to see if this approach can shrink the tumor before surgery and improve outcomes.
Guangzhou, GuangdongAges 18–75 - NCT06884163Recruiting
Hand Eczema Study: Understanding the Immune System at Work
This study examines the immune cells and proteins in chronic hand eczema samples. By comparing skin from affected and healthy areas, researchers hope to find new targets for treatment.
RomeAges 18–65 - NCT04970836Recruiting
Hepatitis B revaccination for young adults in Taiwan
This study looks at how well your immune system responds after getting 1–2 extra doses of the hepatitis B vaccine. It may help doctors understand who needs revaccination and how to strengthen protection.
TaipeiAges 20–36 - NCT07275489Recruiting
Long-term isolation and your immune system
This study looks at how long-term isolation on remote islands affects your immune system. If you are a healthy adult who will spend a year living on the Kerguelen Islands, this trial will track your health over time.
Port-aux-Français, Terres Australes Et Antarctiques FrançaisesAges 18 years+
Hear when a new Immunity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for immunity?
- Yes. Clin2 currently lists 973 recruiting immunity studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a immunity trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a immunity trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.